NRIX — Nurix Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Nurix Therapeutics, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th	2025 November 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	295	309	288	610	593
Net Total Accounts Receivable
Net Total Receivables	6.2	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	311	318	296	619	607
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25.3	29.5	48	45.9	73
Long Term Investments
Other Long Term Assets
Total Assets	477	417	356	669	688
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	66.3	70.7	87	95.9	86.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	134	113	155	142	149
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	342	304	200	527	539
Total Liabilities & Shareholders' Equity	477	417	356	669	688
Total Common Shares Outstanding